Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives-Reference-Cited by-同舟云学术

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

Published:2010-07 Issue:7 Volume:9 Page:560-574
ISSN:1474-1776
Container-title:Nature Reviews Drug Discovery
language:en
Short-container-title:Nat Rev Drug Discov

Author:

Hampel Harald,Frank Richard,Broich Karl,Teipel Stefan J.,Katz Russell G.,Hardy John,Herholz Karl,Bokde Arun L. W.,Jessen Frank,Hoessler Yvonne C.,Sanhai Wendy R.,Zetterberg Henrik,Woodcock Janet,Blennow Kaj

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology,General Medicine

Link

http://www.nature.com/articles/nrd3115.pdf

Reference138 articles.

1. Blennow, K., de Leon, M. J. & Zetterberg, H. Alzheimer's disease. Lancet 368, 387–403 (2006).

2. Klafki, H. W., Staufenbiel, M., Kornhuber, J. & Wiltfang, J. Therapeutic approaches to Alzheimer's disease. Brain 129, 2840–2855, (2006).

3. Garcia-Alloza, M. et al. Existing plaques and neuritic abnormalities in APP:PS1 mice are not affected by administration of the gamma-secretase inhibitor LY-411575. Mol. Neurodegener. 4, 19 (2009).

4. Das, P., Murphy, M. P., Younkin, L. H., Younkin, S. G. & Golde, T. E. Reduced effectiveness of Aβ1–42 immunization in APP transgenic mice with significant amyloid deposition. Neurobiol. Aging 22, 721–727 (2001).

5. Levites, Y. et al. Anti-Aβ42- and anti-Aβ40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model. J. Clin. Invest. 116, 193–201 (2006).

Cited by 552 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baseline serum glutamate: Implications for diagnosis and prediction in mild cognitive impairment and Alzheimer’s disease of the Alzheimer’s Disease Neuroimaging Initiative;Journal of Clinical Neuroscience;2024-11

2. Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer’s disease;Med;2024-09

3. Association of liver function markers and apolipoprotein E ε4 with pathogenesis and cognitive decline in Alzheimer’s disease;Frontiers in Aging Neuroscience;2024-07-24

4. Recent Advances in the Treatment and Management of Alzheimer’sDisease: A Precision Medicine Perspective;Current Topics in Medicinal Chemistry;2024-07

5. Automated diagnosis of schizophrenia based on spatial–temporal residual graph convolutional network;BioMedical Engineering OnLine;2024-06-17